Skip to main content
Veterinary Medicines

HIPRAVIAR-SHS

Authorised
  • Turkey rhinotracheitis virus, strain 1062, Live

Product identification

Medicine name:
HIPRAVIAR-SHS
Active substance:
  • Turkey rhinotracheitis virus, strain 1062, Live
Target species:
  • Chicken (chick)
  • Chicken (layer hen)
  • Chicken (for reproduction)
  • Turkey
Route of administration:
  • Oculonasal use
  • Oral use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain 1062, Live
    2.40
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken (chick)
    • Chicken (layer hen)
    • Chicken (for reproduction)
    • Turkey
  • Oral use
    • Chicken (chick)
    • Chicken (layer hen)
    • Chicken (for reproduction)
    • Turkey
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD01
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-2539-09.04.2015
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 15/04/2022

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 15/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."